Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
API
0
FDF
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 6-hydroxy-8-(1-hydroxy-2-((2-(4-methoxyphenyl)-1,1-dimethylethyl)amino)ethyl)-2h-1,4-benzoxazin-3(4h)-one
2. Bi 1744 Cl
3. Bi-1744 Cl
4. Olodaterol
5. Striverdi Respimat
1. 869477-96-3
2. Olodaterol Hcl
3. Striverdi Respimat
4. Bi 1744 Cl
5. Bi-1744-cl
6. Bi 1744 Hydrochloride
7. Bi-1744 Cl
8. Olodaterol Hydrochloride [usan]
9. Chebi:83309
10. Olodaterol (hydrochloride)
11. 65r445w3v9
12. 2h-1,4-benzoxazin-3(4h)-one, 6-hydroxy-8-((1r)-1-hydroxy-2-((2-(4-methoxyphenyl)- 1,1-dimethylethyl)amino)ethyl)-, Hydrochloride (1:1)
13. 6-hydroxy-8-((1r)-1-hydroxy-2-((2-(4-methoxyphenyl)-1,1-dimethylethyl)amino)ethyl)- 2h-1,4-benzoxazin-3(4h)-one Hydrochloride
14. Striverdi Respimat (tn)
15. 6-hydroxy-8-[(1r)-1-hydroxy-2-[[1-(4-methoxyphenyl)-2-methylpropan-2-yl]amino]ethyl]-4h-1,4-benzoxazin-3-one;hydrochloride
16. Unii-65r445w3v9
17. (r)-6-hydroxy-8-(1-hydroxy-2-((1-(4-methoxyphenyl)-2-methylpropan-2-yl)amino)ethyl)-2h-benzo[b][1,4]oxazin-3(4h)-one Hydrochloride
18. 869477-96-3 (hcl)
19. Schembl560669
20. Bi-1744 Hcl
21. Chembl2105743
22. Dtxsid901027733
23. Amy16778
24. Bcp16765
25. Ex-a2815
26. Olodaterol(bi-1744) Hydrochloride
27. Bdbm50538807
28. Hy-14301a
29. Olodaterol Hydrochloride (jan/usan)
30. Olodaterol Hydrochloride [mi]
31. S5925
32. Akos030524628
33. Olodaterol Hydrochloride [vandf]
34. Olodaterol Hydrochloride [who-dd]
35. Ac-29884
36. As-58291
37. Cs-0021887
38. Olodaterol Hydrochloride [orange Book]
39. D10020
40. A862976
41. Q27156746
42. 2h-1,4-benzoxazin-3(4h)-one, 6-hydroxy-8-[(1r)-1-hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-, Hydrochloride (1:1)
43. 6-hydroxy-8-[(1r)-1-hydroxy-2-{[1-(4-methoxyphenyl)-2-methylpropan-2-yl]amino}ethyl]-2h-1,4-benzoxazin-3(4h)-one Hydrochloride
44. N-[(2r)-2-hydroxy-2-(6-hydroxy-3-oxo-3,4-dihydro-2h-1,4-benzoxazin-8-yl)ethyl]-1-(4-methoxyphenyl)-2-methylpropan-2-aminium Chloride
Molecular Weight | 422.9 g/mol |
---|---|
Molecular Formula | C21H27ClN2O5 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 7 |
Exact Mass | 422.1608497 g/mol |
Monoisotopic Mass | 422.1608497 g/mol |
Topological Polar Surface Area | 100 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 521 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Treatment of cystic fibrosis
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-08-23
Pay. Date : 2023-07-12
DMF Number : 38558
Submission : 2023-07-21
Status : Active
Type : II
NDC Package Code : 64567-0031
Start Marketing Date : 2023-07-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF, CN |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38916
Submission : 2023-09-22
Status : Active
Type : II
Related Excipient Companies
Excipients by Applications
Global Sales Information
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?